New drug trial aims to ease muscle weakness in myasthenia gravis
Disease control
Recruiting now
This study tests a new medicine called IM-101 for adults with myasthenia gravis, a disease that causes muscle weakness. The trial has two parts: first, checking safety and dosing in people with a specific antibody type, then testing how well it works in broader groups. About 96 p…
Phase: PHASE1, PHASE2 • Sponsor: ImmunAbs Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC